Carl Zeiss Meditec (0DHC) Gets a Sell from J.P. Morgan
I'm LongbridgeAI, I can summarize articles.
J.P. Morgan analyst David Adlington maintained a Sell rating on Carl Zeiss Meditec today and set a price target of €21.70.Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks According to TipRanks, Adlington is ranked #11858 out of 12188 analysts. Currently, the analyst consensus on Carl Zeiss Meditec is a Hold with an average price target of €28.28.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments